{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:47:55Z","timestamp":1775882875047,"version":"3.50.1"},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,4,8]]},"DOI":"10.1248\/bpb.b25-00697","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:09:12Z","timestamp":1775599752000},"page":"654-660","source":"Crossref","is-referenced-by-count":0,"title":["Associations between Anticholinergic Use and Dementia Risk in a Prevalent-User Cohort: Analysis of Japanese Medication Histories as Real-World Data"],"prefix":"10.1248","volume":"49","author":[{"given":"Hilomi","family":"Iwai","sequence":"first","affiliation":[{"name":"Graduate Degree Program of Health Data Science, Graduate School of Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimako","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miyata","sequence":"additional","affiliation":[{"name":"Graduate Degree Program of Health Data Science, Graduate School of Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"},{"name":"Teikyo University Graduate School of Public Health, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yamato","sequence":"additional","affiliation":[{"name":"SUNDRUG Co., Ltd., 1\u201338\u20131 Wakamatsucho, Fuchu, Tokyo 183\u20130005, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kogawa","sequence":"additional","affiliation":[{"name":"SUNDRUG Co., Ltd., 1\u201338\u20131 Wakamatsucho, Fuchu, Tokyo 183\u20130005, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Yamori","sequence":"additional","affiliation":[{"name":"Japan Pharmacists Education Center, 2\u20133\u20131 Nishi-shimbashi, Minato-ku, Tokyo 105\u20130003, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okura","sequence":"additional","affiliation":[{"name":"Graduate Degree Program of Health Data Science, Graduate School of Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"},{"name":"Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Livingston G, Huntley J, Liu KY, <i>et al<\/i>. Dementia prevention, intervention, and care: 2024 report of the <i>Lancet<\/i> standing Commission. <i>Lancet<\/i>, <b>404<\/b>, 572\u2013628 (2024).","DOI":"10.1016\/S0140-6736(24)01296-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fang M, Hu J, Weiss J, Knopman DS, Albert M, Windham BG, Walker KA, Sharrett AR, Gottesman RF, Lutsey PL, Mosley T, Selvin E, Coresh J. Lifetime risk and projected burden of dementia. <i>Nat. Med.<\/i>, <b>31<\/b>, 772\u2013776 (2025).","DOI":"10.1038\/s41591-024-03340-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Seidel D, Thyrian JR. Burden of caring for people with dementia - comparing family caregivers and professional caregivers. A descriptive study. <i>J. Multidiscip. Healthc.<\/i>, <b>12<\/b>, 655\u2013663 (2019).","DOI":"10.2147\/JMDH.S209106"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gulle BT, Tozduman B. Population attributable fraction of modifiable risk factors for dementia in Turkey. <i>Dementia<\/i>, <b>2025<\/b>, 14713012251357162 (2025).","DOI":"10.1177\/14713012251357162"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kinoshita S, Kishimoto T. Dementia in Japan: a societal focus, <i>Lancet Neurol.<\/i>, <b>22<\/b>, 1101\u20131102 (2023). &lt;https:\/\/pubmed.ncbi.nlm.nih.gov\/37977703\/&gt;.","DOI":"10.1016\/S1474-4422(23)00415-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. <i>JAMA Intern. Med.<\/i>, <b>175<\/b>, 401\u2013407 (2015).","DOI":"10.1001\/jamainternmed.2014.7663"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tanaka S, Miyata S, Yamato J, Kumagai S, Kogawa M, Yamori T, Irie M, Nakatani E, Okura T. Evaluation of dementia risk in patients taking medication for overactive bladder using medication history in Japan. <i>Translational and Regulatory Sciences<\/i>, <b>6<\/b>, 10\u201314 (2024).","DOI":"10.33611\/trs.2024-001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. <i>JAMA Intern. Med.<\/i>, <b>179<\/b>, 1084\u20131093 (2019).","DOI":"10.1001\/jamainternmed.2019.0677"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Grossi CM, Mattishent K, Bennett K, Campbell NL, Boustani M, Robinson L, Brayne C, Matthews FE, Savva GM. Anticholinergic drugs and risk of dementia: case-control study. <i>BMJ<\/i>, <b>361<\/b>, k1315 (2018).","DOI":"10.1136\/bmj.k1315"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. <i>J. Urol.<\/i>, <b>202<\/b>, 558\u2013563 (2019).","DOI":"10.1097\/JU.0000000000000309"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nambiar AK, Bosch R, Cruz F, Lemack GE, Thiruchelvam N, Tubaro A, Bedretdinova DA, Amb\u00fchl D, Farag F, Lombardo R, Schneider MP, Burkhard FC. EAU guidelines on assessment and nonsurgical management of urinary incontinence. <i>Eur. Urol.<\/i>, <b>73<\/b>, 596\u2013609 (2018).","DOI":"10.1016\/j.eururo.2017.12.031"},{"key":"12","unstructured":"12) <i>MANUAL OF THERAPEUTIC AGENTS 2024<\/i>. Igakushoin, Tokyo (2024)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S. Glucose tolerance status and risk of dementia in the community: the Hisayama study. <i>Neurology<\/i>, <b>77<\/b>, 1126\u20131134 (2011).","DOI":"10.1212\/WNL.0b013e31822f0435"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer\u2019s and vascular dementia three decades later. <i>Dement. Geriatr. Cogn. Disord.<\/i>, <b>28<\/b>, 75\u201380 (2009).","DOI":"10.1159\/000231980"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. <i>Neurology<\/i>, <b>64<\/b>, 277\u2013281 (2005).","DOI":"10.1212\/01.WNL.0000149519.47454.F2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, Schrag D, Takeuchi M, Uyama Y, Zhao L, Skali H, Solomon S, Jacobus S, Hughes M, Packer M, Wei L-J. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. <i>J. Clin. Oncol.<\/i>, <b>32<\/b>, 2380\u20132385 (2014).","DOI":"10.1200\/JCO.2014.55.2208"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Royston P, Parmar MKB. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. <i>BMC Med. Res. Methodol.<\/i>, <b>13<\/b>, 152 (2013).","DOI":"10.1186\/1471-2288-13-152"},{"key":"18","unstructured":"18) Pharmaceuticals and Medical Devices Agency. \u201cThe 4th Data Science Roundtable Conference.\u201d: &lt;https:\/\/www.pmda.go.jp\/review-services\/symposia\/0060.html&gt;, accessed 28 December, 2025."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Malcher MF, Droupy S, Berr C, Ziad A, Huguet H, Faillie J-L, Serrand C, Mura T. Dementia associated with anticholinergic drugs used for overactive bladder: a nested case-control study using the french national medical-administrative database. <i>J. Urol.<\/i>, <b>208<\/b>, 863\u2013871 (2022).","DOI":"10.1097\/JU.0000000000002804"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wagg A, Khullar V, Marschall-Kehrel D, Michel MC, Oelke M, Darekar A, Bitoun CE, Weinstein D, Osterloh I. Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial. <i>J. Am. Geriatr. Soc.<\/i>, <b>61<\/b>, 185\u2013193 (2013).","DOI":"10.1111\/jgs.12088"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shiho M, Tanaka S, Nakatani E, Kurosawa T, Kubo Y, Deguchi Y, Okura T. Brain distribution and muscarinic receptor occupancy of an active metabolite of fesoterodine in rats. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>392<\/b>, 100058 (2025).","DOI":"10.1016\/j.jpet.2024.100058"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sofi F, Valecchi D, Bacci D, Abbate R, Gensini GF, Casini A, Macchi C. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. <i>J. Intern. Med.<\/i>, <b>269<\/b>, 107\u2013117 (2011).","DOI":"10.1111\/j.1365-2796.2010.02281.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Anstey KJ, von Sanden C, Salim A, O\u2019Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. <i>Am. J. Epidemiol.<\/i>, <b>166<\/b>, 367\u2013378 (2007).","DOI":"10.1093\/aje\/kwm116"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kuiper JS, Zuidersma M, Oude Voshaar RC, Zuidema SU, van den Heuvel ER, Stolk RP, Smidt N. Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies. <i>Ageing Res. Rev.<\/i>, <b>22<\/b>, 39\u201357 (2015).","DOI":"10.1016\/j.arr.2015.04.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, Evans SJW, Pocock SJ. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. <i>Lancet Diabetes Endocrinol.<\/i>, <b>3<\/b>, 431\u2013436 (2015).","DOI":"10.1016\/S2213-8587(15)00033-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, Yu J-T. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. <i>Eur. J. Epidemiol.<\/i>, <b>32<\/b>, 31\u201342 (2017).","DOI":"10.1007\/s10654-017-0225-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Meng X, D\u2019Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. <i>PLOS ONE<\/i>, <b>7<\/b>, e38268 (2012).","DOI":"10.1371\/journal.pone.0038268"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer\u2019s disease: systematic review and meta-analysis of community-based cohort studies. <i>Br. J. Psychiatry<\/i>, <b>202<\/b>, 329\u2013335 (2013).","DOI":"10.1192\/bjp.bp.112.118307"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air pollution and dementia: a systematic review. <i>J. Alzheimers Dis.<\/i>, <b>70<\/b>(s1), S145\u2013S163 (2019).","DOI":"10.3233\/JAD-180631"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Suzuki M, Yamamoto M, Shiratori T, Naito A, Nakamura M. Evaluation of trends in prescription drugs for overactive bladder in Japanese patients. <i>Int. J. Urol.<\/i>, <b>30<\/b>, 331\u2013333 (2023).","DOI":"10.1111\/iju.15117"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b25-00697\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:02:26Z","timestamp":1775880146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b25-00697\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00697","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"article-number":"b25-00697"}}